Neuphoria Therapeutics (NEUP) Receivables (2020 - 2026)
Neuphoria Therapeutics (NEUP) posted Receivables of $1.62 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), compared with $11,948 a year earlier and down 32.7% from the prior quarter.
Powered by 
Analysis
Neuphoria Therapeutics (NEUP) Receivables (2020 - 2026) Analysis & Trends
Since fiscal Q4 2020, Neuphoria Therapeutics has reported Receivables for 13 quarters.
- Annual Receivables shows a five-year compound annual growth rate of 0.5% (FY2021 to FY2026).
- In prior fiscal years, Neuphoria Therapeutics' Receivables was $11,948 in FY2025 (-94.6%), $223,038 in FY2024 (-73.7%), $848,708 in FY2023 (-91.2%) and $9.67 million in FY2022 (+510.8%).
- Quarterly Receivables has run from a low of $1,758 in fiscal Q1 2026 to a high of $4.86 million in fiscal Q4 2022 over five years.
- According to Business Quant data, Receivables for the three prior fiscal quarters was $2.41 million (Q3 2026), $1.6 million (Q2 2026) and $1,758 (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Neuphoria Therapeutics | 437.56 Mn | 362.37 Mn | - | 1.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.62 Mn |
| Mar 31, 2026 | 2.41 Mn |
| Dec 31, 2025 | 1.60 Mn |
| Sep 30, 2025 | 1,758.00 |
| Jun 30, 2025 | 11,948.00 |
| Mar 31, 2025 | 24,592.00 |
| Dec 31, 2024 | 35,561.00 |
| Sep 30, 2024 | 216,585.00 |
| Jun 30, 2024 | 223,038.00 |
| Jun 30, 2023 | 425,168.81 |
| Jun 30, 2022 | 4.67 Mn |
| Jun 30, 2021 | 847,748.22 |
| Jun 30, 2020 | 1.25 Mn |
API Access
Neuphoria Therapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=NEUP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "NEUP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=NEUP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();